BioAstin Reduces CRP Levels by
over 20% in Human Clinical Trial

News was just released last week that BioAstin® Natural Astaxanthin reduced C-reactive protein in a double blind, placebo controlled human clinical trial. The treatment group’s average CRP level went down an impressive 20.7% in just 8 weeks when taking BioAstin. Analysis of the results showed that they were statistically significant.

C-reactive protein is a key measurement of systemic or “silent” inflammation. “Silent” inflammation is inflammation that is present at low levels in the body for an extended period of time. Continued exposure to silent inflammation is theorized to be a root cause of a multitude of life threatening diseases. The American Heart Association has suggested that testing CRP levels in the blood may be a new measurement to assess cardiovascular disease risk. The independent researcher who completed this study said, “Other research suggests that systemic or silent inflammation may be implicated in many other life threatening diseases such as cancer, heart disease, stroke, diabetes and Alzheimer’s among others.”

There is a growing body of research demonstrating that Astaxanthin is a safe, effective anti-inflammatory that works through multiple pathways. Research done at two different universities in 2003 demonstrated the different anti-inflammatory pathways by which Astaxanthin combats inflammation. And previous clinical trials with BioAstin by Cyanotech have shown that BioAstin shows benefits on people with a variety of inflammatory conditions such as rheumatoid arthritis, carpal tunnel syndrome, joint and muscle soreness after exercise and as an internal sunblock (another inflammatory condition since sunburn is an inflammation of the body’s largest organ, the skin).

BioAstin® Natural Astaxanthin is the best selling brand of Astaxanthin for human nutrition in the world.

For more information on BioAstin® Natural Astaxanthin, please call 808.334.9415 or e-mail bcapelli@cyanotech.com

To include a colleague for future Cyanotech News, please send email address to bcapelli@cyanotech.com